Send feedback

A2ML1 p.Ala1039=

c.3117G>A · rs370178808 · VCV1143571

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00644%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.43GERP -1.1, phastCons 0.069
Overall
CADD12.2PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00644% European (non-Finnish) · 76/1,179,984 alleles
Filtering AF 0.00528% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00482%
Overall 0.00496% 80/1,613,922 alleles · very rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00644% 15,526
South Asian 0.00329% 30,361
Remaining individualsnot grpmax-eligible 0.0016% 62,480

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
A2ML1
Protein
p.Ala1039=
Coding
c.3117G>A
MANE Select
NM_144670
dbSNP
rs370178808
Type
single nucleotide variant
Location
chr12:8857955 (GRCh38)
Gene constraint
LOEUF 0.953 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 80.61 · 5 PDB
Residue 1039
an α-helix; a disulfide bond; a UniProt-annotated variant site (risk factor for otitis media)
Full A2ML1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/a2ml1-p-ala1039 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown